Hydration and Outcome in Older Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01703715

Acronym

HOOP

Enrollment

200

Registered

2012-10-10

Start date

2012-08-31

Completion date

2014-05-31

Last updated

2014-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dehydration

Keywords

Hydration, Elderly patients, Age 65 years and over, Admitted acutely to medical admissions ward

Brief summary

Dehydration is recognised as a major issue in healthcare. Recovery after illness, extended length of stay, pressure sores and slow tissue recovery can all be impacted by dehydration. One of the biggest problems for many people with regard to getting a drink is easy, independent access - if they can't reach the jug/cup without a struggle then they often will go thirsty and potentially become dehydrated. The purpose of this study is to investigate the impact of dehydration on outcome in patients 65 years and over. Furthermore we aim to assess the impact of providing easy, 24 hour, independently accessible fluids on reducing dehydration as well as improving patient experience. We hypothesise that patients who are dehydration will take longer to recover from illness and stay in hospital for longer periods.

Interventions

DEVICEThe Hydrant

The Hydrant is a new form of drinking system that may be used to provide continuous access to hydration will be given to 20 patients. 10 of the patients will have mild cognitive impairment with Mini Mental State Examination less than 24 and 10 with normal cognitive function. Patients and staff will be interviewed to assess the feasibility of the hydrant.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

65 Years to No maximum

Healthy volunteers

Inclusion criteria

1. \- All patients of 65 years and over that are admitted acutely to medical wards 2. \- Ward staff who have been working in the clinical area for the duration of the trial (The Hydrant part of the study).

Exclusion criteria

1. \- Patients who are moribund 2. \- Patients who are doubly incontinent 3. \- Patients on the end of life pathway 4. \- Patients with terminal illness with a known life expectancy less than 3 months

Design outcomes

Primary

Measure	Time frame
Serum Osmolality	At admission and 48hrs post admission to hospital

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026